Taken together, melittin protects against hypoxia-induced NSCLC cell proliferation, glycolysis, and angiogenesis through inactiving YAP/HIF-1α pathway via up-regulation of LATS2. Here, LATS2 is linked to non-small cell lung carcinoma.